title: Long-term follow-up for multidrug-resistant tuberculosis.
abstract: Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: Sonya S
authors.initials: SS
authors.lastname: Shin
authors.forename: Jennifer J
authors.initials: JJ
authors.lastname: Furin
authors.forename: Felix
authors.initials: F
authors.lastname: Alcántara
authors.forename: Jaime
authors.initials: J
authors.lastname: Bayona
authors.forename: Epifanio
authors.initials: E
authors.lastname: Sánchez
authors.forename: Carole D
authors.initials: CD
authors.lastname: Mitnick
mesh_terms: D000995:Antitubercular Agents; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010568:Peru / Q000453:epidemiology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*
chemical_list: D000995:Antitubercular Agents